Comparative bioavailability studies of indomethacin from two-controlled release formulations in healthy albino sheep

Indian Journal of Pharmaceutical Sciences

Volumn 68, Issue 6, 2006, Pages 760-763

  Gowda, D V ^a   Shivakumar, H G ^a  

^a JSS COLLEGE OF PHARMACY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CETOSTEARYLIC ALCOHOL; HYDROGEN PEROXIDE; INDOMETACIN;

ALBINISM; ARTICLE; BIOEQUIVALENCE; BLOOD LEVEL; BLOOD SAMPLING; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; DRUG BIOAVAILABILITY; DRUG FORMULATION; IN VIVO STUDY; NONHUMAN; SHEEP; SINGLE DRUG DOSE; STATISTICAL ANALYSIS; STUDENT T TEST;

EID: 33947382173     PISSN: 0250474X     EISSN: None     Source Type: Journal    
DOI: 10.4103/0250-474X.31010     Document Type: Article

References (20)

1. Eric G Boyce, In; Herfindal, E. and Gourley, D.R., Eds., Text book of Therapeutics Drug and Disease Management, 7th Edn., Lippincott Williams and Wilkins, New York, 2000, 650.
2. Flower, R.J., Moncada, S. and Vane, J.R., In; Rall, L.S. and Murad, F., Eds., The Pharmacological Basis of Therapeutics., 7th Edn., Maxwell Publishing Co., New York, 1985, 695.
3. Schiff, M., Amer. J. Med., 1997, 102, 118.
4. Cotton, R.B., Clin. Perinat., 1987, 14, 621.
5. Aloan, G., Orme, M., Bertilsson, L., Ekstrand, R., and Palmer, L., Clin. Pharm. Ther., 1975, 18, 364.
6. Brook, P.M., Bell M., Walker, J. J., Kennedy, A.C., Sturrock, R.O., and Dick W.C, Ann. Rheum. Dis., 1975, 34, 465.
7. Baber, N., Halliday, L., Sibean, R., Littler T., and Orme Jr. L.E., Clin. Pharm. Ther., 1978, 24, 298.
8. Anony, M.U., Rheum., 1996, 39, 723.
9. AL Muhrok, G.M., AL Meshal, M.A., and AL Angary, A.A., Drug Develop. Ind. Pharm., 1993, 19, 1906.
10. Roy, S. and Gupta, P. K., Drug Develop. Ind. Pharm., 1993, 19, 1965.
11. Kwan, K.C., Breault, G.C., Davis, R.L., Lei, B.W., Czerwinski, A.W., Basselaar, G.H., and Duggan, D.E., J. Pharm. Kinet. Biopharm., 1978, 6, 451.
12. Helleberg, L., Clin. Pharmacokinet., 1981, 6, 245.
13. Johnson A.G. and Roy, J.E., Ther. Drug. Monit., 1992, 14, 61.
14. Quickcalkcomputer pharmacokinetic calculations programme, Synchron Research Services Pvt.Ltd., Ahmedabad, India.2001.
15. Day, R.O., Graham, G.G., Willams, K.W., Champion G.D., and Dejager J., Clin. P.col. Ther., 1987, 33, 383.
16. Avgerinos, A and Malamataris, S., Int. J. Pharm., 1990, 63, 77.
17. O'Brien, M.J., McCauley, J., and Cohen, E., In; Analytical Profiles of Drug Substances, Vol. 13., American Academic Press., New York, 1984, 21.
18. Food and Drug administration, Bioavailability Protocol Guideline and NDA submission, 1977.
19. Brockmeir, D., Acta. Pharmacol. Technol., 1986, 32, 16.
20. FDA Guidelines for industry, Dissol. Tech., 1997, 1, 23.